Mineralys Therapeutics (MLYS) Rule 144: 3,000-share cashless exercise
Rhea-AI Filing Summary
Mineralys Therapeutics, Inc. reported a Rule 144 notice for the sale of 3,000 shares of Common Stock via a broker-assisted cashless exercise on 06/17/2026. The filing shows proceeds of $75,000 and identifies the seller as Daphne Karydas. The transaction is described as an exercise of employee stock options.
Positive
- None.
Negative
- None.
Insights
Rule 144 notice documents a cashless exercise and resale intent for 3,000 shares.
The filing lists a broker-assisted cashless exercise on 06/17/2026 that generated $75,000 for the reported 3,000 shares. It explicitly states the method as an exercise of employee stock options, which is a common compensation liquidity event.
Timing and distribution mechanics beyond the exercise are not detailed here; subsequent Form 4s or resale filings would show any open-market sales. Cash-flow treatment is as stated in the excerpt.